Boston Scientific Encouraged By Luminize AF First-In-Human Data

Data from the AF-FICIENT I study, presented at the European Heart Rhythm Association in Lisbon, Portugal, support Boston Scientific's development of the Luminize atrial fibrillation ablation catheter. Luminize has built-in digital cameras for visual guidance and sensing electrodes on the balloon to assess real-time vein isolation.

Amin Al-Ahmad of Texas Cardiac Arrhythmia presented results of the AF-FICIENT I first-in-human study supporting the safety and efficacy of Boston Scientific Corp.'s Luminize radiofrequency balloon catheter for atrial fibrillation at the European Heart Rhythm Association meeting in Lisbon on March 17.

Luminize helps locate the source of arrhythmia with a built-in digital camera and sensing electrodes on the balloon to assess real-time vein isolation. It has customizable ablation electrodes for delivering...

More from Cardiology

More from Device Area